Novel parameter for cancer chemosensitivity to fibroblast growth factor receptor inhibitors.

Saved in:
Bibliographic Details
Title: Novel parameter for cancer chemosensitivity to fibroblast growth factor receptor inhibitors.
Authors: Kitano S; iACT-Colon Cancer Project, Kyoto University Hospital, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan., Yamamoto T; iACT-Colon Cancer Project, Kyoto University Hospital, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Medical Research Institute, Kitano Hospital, Osaka, Japan., Taketo MM; iACT-Colon Cancer Project, Kyoto University Hospital, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Medical Research Institute, Kitano Hospital, Osaka, Japan.
Source: Cancer science [Cancer Sci] 2022 Nov; Vol. 113 (11), pp. 4005-4010. Date of Electronic Publication: 2022 Aug 30.
Publication Type: Journal Article
Journal Info: Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1349-7006
DOI:10.1111/cas.15523